Helius Medical Technologies (HSDT)
(Delayed Data from NSDQ)
$0.70 USD
-0.08 (-10.35%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $0.74 +0.04 (5.26%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
HSDT 0.70 -0.08(-10.35%)
Will HSDT be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for HSDT based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for HSDT
Nevro (NVRO) Reports Q1 Loss, Tops Revenue Estimates
AxoGen (AXGN) Reports Q1 Loss, Lags Revenue Estimates
HSDT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Wall Street Analysts Predict a 1249.93% Upside in Helius Medical Technologies, Inc. (HSDT): Here's What You Should Know
How Much Upside is Left in Helius Medical Technologies, Inc. (HSDT)? Wall Street Analysts Think 1183.3%
Helius Medical Technologies, Inc. (HSDT) Reports Q2 Loss, Tops Revenue Estimates
Other News for HSDT
7 F-Rated Growth Stocks to Avoid Right Now: June 2024
Helius Medical Technologies Enhances Equity Plan and Confirms Directors
12 Health Care Stocks Moving In Thursday's After-Market Session
Helius Medical Technologies, Inc. Completes Site Participation Enrollment for its U.S. Registrational Program in Stroke
Helius Medical completes participation enrollment for stroke program in the U.S.